Prudential Financial
SIOX

Prudential Financial’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Prudential Financial’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,535
Closed -$1.46M – 2368
2017
Q3 		$1.46M Buy
26,535
+16,514
+165% +$2.79M ﹤0.01% 1715
2017
Q2 		$1.86M Buy
10,021
+8,770
+701% +$1.54M ﹤0.01% 1598
2017
Q1 		$149K Hold
1,251
– – ﹤0.01% 2266
2016
Q4 		$124K Sell
1,251
-250
-17% -$26.3K ﹤0.01% 2282
2016
Q3 		$169K Buy
+1,501
New +$180K ﹤0.01% 2236

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IPLA
Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Prudential Financial's SIOX Position: Q4 2017 in Review

Prudential Financial sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2017, closing a stake of 26,535 shares — an estimated $1.46M sold.

Prudential Financial first reported a position in SIOX in Q3 2016 and held it in 5 quarters. The position peaked at $1.86M in Q2 2017. 104 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.

  • Prudential Financial reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Prudential Financial sold 26,535 Sio Gene Therapies Inc. Common Stock shares in Q4 2017, an estimated $1.46M.
  • Prudential Financial first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2016 and held it in 5 quarters.
  • Prudential Financial's Sio Gene Therapies Inc. Common Stock position peaked at $1.86M in Q2 2017.
  • 104 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2017.

Based on Prudential Financial's 13F filing for Q4 2017, filed 13 Feb 2018.